Established in 1987 as the Aids Clinical Trials Unit (ACTU), the Washington University ACTU has been a highly productive participant in the AIDS Clinical Trials Group and is funded by the National Institute of Allergy and Infectious Diseases. Centrally located in the Midwest, it draws participants from Missouri, Illinois, Arkansas, Kansas, Tennessee, Nebraska and Oklahoma. Within the Division of Infectious Diseases, this ACTU is considered among the finest in the world.
The Washington University Infectious Diseases Clinical Research Unit (ID-CRU), as it is now known, is highly regarded for their expertise and is well established in the community. Led by Rachel Presti, MD, PhD, the ID-CRU provides access to HIV and Infectious Disease research opportunities, community outreach and education.
Team
